CClinicalTrials.gg
Not yet recruitingNCT07033871CGACDM - OlderUpdated Jun 24, 2025

Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study (CGACDM - Older Adults in China)

An observational study in Comprehensive Geriatric Assessment, Chronic Disease Management and Older Adults (65 Years and Older), sponsored by Henan Provincial People's Hospital. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-24.

Sponsored by Henan Provincial People's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
60 Years and older
Sex
All
01

Study summary

With the continuous development of China's economy and the improvement of medical standards, the life expectancy of the Chinese population has significantly increased. Against the backdrop of accelerating aging in China, the incidence of age-related chronic non-communicable diseases (NCDs), such as cardiovascular and cerebrovascular diseases and chronic respiratory diseases, has risen remarkably. These diseases are characterized by multiple comorbidities, high disability rates, and high mortality rates, severely compromising the quality of life of older adults, exacerbating family burdens, and straining healthcare systems. This constitutes one of the major challenges faced by aging societies. Therefore, early detection and intervention of chronic diseases in older adults are critical measures to address population aging.

Comprehensive geriatric assessment (CGA), a core specialty of geriatric medicine, serves as a fundamental framework for the clinical identification of geriatric syndromes and multidisciplinary management. It is emerging as a key pathway to promote "healthy aging." Guided by this premise, this study aims to explore the application value of CGA in managing chronic diseases among older adults, with the goal of achieving full-cycle management for early detection, diagnosis, and treatment of chronic conditions in China's elderly population.

02

Conditions studied

  • Comprehensive Geriatric Assessment
  • Chronic Disease Management
  • Older Adults (65 Years and Older)

Keywords

  • Comprehensive Geriatric Assessment
  • Chronic Disease Management
  • Older Adults
03

In context

Lead sponsor

Henan Provincial People's Hospital is the lead sponsor of 63 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consisted of patients with chronic diseases in the elderly who underwent comprehensive geriatric assessment and management. Chronic diseases in the elderly included but were not limited to chronic heart failure, chronic obstructive pulmonary disease, cognitive dysfunction, and so on.

Inclusion criteria

  • 1. Aged 60 years or older 2. Diagnosed with chronic diseases in the circulatory, respiratory, digestive, nervous, or endocrine systems, consistent with corresponding disease diagnostic criteria; 3. Availability of complete medical records; 4. Clear consciousness and ability to independently answer questions; 5. Signed informed consent form.

Exclusion criteria

Exclusion Criteria:

  • 1. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances).

    2. Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.

    3. Current participation in a randomised interventional clinical trial.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Elderly patients with chronic diseases

    The study population consisted of patients with chronic diseases in the elderly who underwent comprehensive geriatric assessment and management. Chronic diseases in the elderly included but were not limited to chronic heart failure, chronic obstructive pulmonary disease, cognitive dysfunction, and so on. We compared various biochemical indexes, cardiac function indexes, quality of life, and the occurrence of long-term adverse events before and after the comprehensive geriatric assessment and management.

    Diagnostic Test: comprehensive geriatric assessment

  • Healthy elderly population

    The control group was composed of elderly subjects without evidence of chronic diseases. Chronic diseases was excluded by performing a complete medical history, a comprehensive physical examination, and an echocardiogram.

    Diagnostic Test: comprehensive geriatric assessment

Interventions

  • Diagnostic testcomprehensive geriatric assessment

    The comprehensive geriatric assessment (CGA) is a multi dimensional diagnostic process used to determine the medi cal, psychological, and functional capabilities of a frail elderly person to develop a coordinated and integrated plan for treat ment and long-term follow-up.

06

What researchers measure

Primary outcomes

  1. Major adverse events (MAE)

    Major adverse events (MAE) in overall population, defined as composite of all-cause death, Heart Failure hospitalization, recurrent myocardial infarction, stroke, etc.

    Time frame: These data is collected during follow-up visit at 3/6/12/24/36 months after discharge

Other outcomes

  1. Age for each participant

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  2. Gender for each participant

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  3. Height for each participant

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  4. Weight for each participant

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  5. Contact information for each participant

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  6. Past Medical History including disease history, surgical history, and family medical history

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  7. Lifestyle including smoking history and drinking, specify how many years smoking or drinking lasted and detail quantity per day

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  8. blood biochemical index:blood lipid

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  9. blood biochemical index:blood glucose

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  10. blood biochemical index:uric acid

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  11. blood biochemical index:urea

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  12. blood biochemical index:creatinine

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  13. blood biochemical index:C reactive protein

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  14. blood biochemical index:D-dimer

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  15. blood biochemical index:NT-proBNP

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  16. Cardiac ultrasound

    The whole results of echocardiography report will be recorded. The indicates which can reflect cardiac function including Left ventricular ejection fraction, left ventricular end diastolic diameter, E/A ratio of bicuspid valve will be used to calculate the association with metabolites.

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  17. Drug treatment

    Oral drug therapy, including antiplatelet drugs, antihypertensive drugs, lipid-lowering drugs, etc.

    Time frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  18. Comprehensive Geriatric Assessment: Frailty

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  19. Comprehensive Geriatric Assessment: Sarcopenia

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  20. Comprehensive Geriatric Assessment: Falls

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  21. Comprehensive Geriatric Assessment: Disability

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  22. Comprehensive Geriatric Assessment: Dysphagia

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  23. Comprehensive Geriatric Assessment: Malnutrition

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  24. Comprehensive Geriatric Assessment: Urinary incontinence

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  25. Comprehensive Geriatric Assessment: Fecal incontinence

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  26. Comprehensive Geriatric Assessment: Constipation

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  27. Comprehensive Geriatric Assessment: Cognitive impairment

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  28. Comprehensive Geriatric Assessment: Anxiety state

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  29. Comprehensive Geriatric Assessment: Depressive state

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  30. Comprehensive Geriatric Assessment: Sleep disorders

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  31. Comprehensive Geriatric Assessment: Pain

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  32. Comprehensive Geriatric Assessment: Social support

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

  33. Comprehensive Geriatric Assessment: Home environment

    Time frame: These data were collected from the comprehensive geriatric assessment process within an average of 1 week after sample recruitment

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07033871
Lead sponsor
Henan Provincial People's Hospital
Collaborators
Geriatrics Research Institute of Henan Provincial People's Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases
Responsible party
Sponsor
First posted
Jun 24, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
May 1, 2030 (estimated)
Completion
May 1, 2030 (estimated)
Last update
Jun 24, 2025

Study contacts

Yang Xinying Yang Xinying
Contact
xinyingyang150@163.com
0371-87160164

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion